Scarica l'app Stockscreener
0.7755
4.73%
0.035
Dopo l'orario di chiusura:
.80
0.0245
+3.16%
Dare Bioscience Inc Borsa (DARE) Ultime notizie
Daré Bioscience launches Flora Sync LF5 for direct revenue - scanx.trade
Warrants covering about 45% of existing shares await a vote at Daré Bioscience (NASDAQ: DARE). - Stock Titan
Dare Bioscience Inc (DARE) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Daré Bioscience publishes phase 1 sildenafil cream study data - Investing.com
Dare Bioscience (DARE) Reports Phase 1 Trial Results for Topical Sildenafil Cream - GuruFocus
Daré Bioscience publishes phase 1 sildenafil cream study data By Investing.com - Investing.com India
Sildenafil cream showed 187-fold lower peak blood levels than an oral dose - Stock Titan
Form 8K Dare Bioscience Inc For: 11 September By Investing.com - Investing.com Australia
Dare Bioscience amends bylaws to lower quorum for shareholder meetings By Investing.com - Investing.com Australia
Daré Bioscience Updates Bylaws to Ease Shareholder Quorum - TipRanks
Dare Bioscience amends bylaws to lower quorum for shareholder meetings - Investing.com
Daré Bioscience at H.C. Wainwright conference: turning to sales By Investing.com - Investing.com Canada
Daré Bioscience at H.C. Wainwright conference: turning to sales - Investing.com
Daré Bioscience Presentation for H.C. Wainwright 28th Annual Global Investment Conference Now Available On-Demand - The Manila Times
Daré Bioscience Presentation for H.C. Wainwright 28th - GlobeNewswire
Daré Bioscience Updates Investors with New Presentation - TipRanks
DARE|Dare Bioscience Inc|Price:0.713|Chg%:-0.008 - TradingKey
Dare Bioscience (NASDAQ: DARE) Eyes Up to $12.4M from Warrants to Boost 503B and Consumer Health Initiatives - kalkinemedia.com
Dare Bioscience, Inc. SEC Filing (Sep 4, 2026) - Stock Titan
Dare Bioscience Inc (DARE) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Dare Bioscience Inc (DARE) Key Financial Ratios – Valuation, Profitability & More - Value Research
Dare Bioscience (DARE) Secures $908K NIH Grant Amidst Challengin - GuruFocus
Daré Bioscience receives $908,000 NIH award for preterm birth program - Investing.com India
Daré Bioscience receives $908,000 NIH award for preterm birth program By Investing.com - Investing.com Nigeria
Daré Bioscience Announces New NIH Funding Award for - GlobeNewswire
Lind Global’s capped stake in Dare Bioscience (NASDAQ: DARE) tops key ownership threshold - Stock Titan
Dare Bioscience Inc (DARE) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Daré Bioscience CEO, Sabrina Martucci Johnson, Participates in the Virtual Investor “Why Now” On-Demand Series - Barchart.com
IPO Databook: Daré Bioscience (DARE US)Aug 2026 - Smartkarma
Daré Bioscience publishes sildenafil cream study results - Investing.com
Daré Bioscience publishes sildenafil cream study results By Investing.com - Investing.com India
Daré Bioscience’s Sildenafil Cream Data in Postmenopausal Women Published in MenopauseThe Journal of The Menopause Society - Barchart.com
Daré Bioscience CEO Outlines Commercial Transformation, Pipeline Momentum and Potential Key Catalysts in Virtual Investor CEO Connect Segment - Yahoo Finance
L1 Capital caps Dare Bioscience (DARE) stake at 9.99% - Stock Titan
Drugmakers still struggling to keep up with spiking estrogen patch demand - AOL.com
Daré Bioscience (DARE) Q2 2026 Earnings Call Transcript - AOL.com
Dare Bioscience (NASDAQ: DARE) sets up $12.4M in potential warrant cash - Stock Titan
DARÉ Bioscience CEO Sabrina Martucci Johnson Named to Forbes 2026 “50 Over 50: Innovation” List - sahmcapital.com
Forbes puts a women's health biotech CEO on its 2026 innovation list - Stock Titan
Dare Bioscience Inc (DARE) (Q2 2026) Earnings Call Highlights: C - GuruFocus
Dare Bioscience Prices $6.0 Million Registered Direct Offering - Minichart
Form 8K Dare Bioscience Inc For: 17 August By Investing.com - Investing.com Nigeria
Daré Bioscience Raises ~$6 Million in Equity Offering at $1.37 With Attached Warrants - TradingView
H.C. Wainwright reiterates Dare Bioscience stock rating at buy By Investing.com - Investing.com Canada
Dare Bioscience Inc (DARE) (Q2 2026) Earnings Call Highlights: Commercial Launch Milestones and ... - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
Q2 2026 Dare Bioscience Inc Earnings Call Transcript - GuruFocus
Maxim Group Maintains Dare Bioscience(DARE.US) With Buy Rating, Maintains Target Price $8 - Moomoo
H.C. Wainwright Maintains Dare Bioscience(DARE.US) With Buy Rating, Maintains Target Price $12 - Moomoo
3.06%
2.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):